Grantors & Exhibitors

EY

Fraud Investigation & Dispute Services, Life Sciences team

Industry insight and global experience: the intelligent connection

Tighter competition, regulatory scrutiny and tough enforcement heighten the risk of litigation and non-compliance. In your industry, compliance issues and risk factors need to be addressed at every turn from research and development to marketing strategies and supply chain integrity. And the scrutiny of regulators and customers alike is increasing and rapidly changing.

Our professionals understand the complex issues facing pharmaceutical, biotechnology and medical device companies. By making the intelligent connection between your business operations, markets and third-party relationships, we can help you get to the root cause of problems arising from impropriety. Our dedicated team includes CPAs, government contract analysts, economists, licensed pharmacists and certified fraud examiners, as well as former pharmaceutical executives, ethics and compliance officers and government auditors, investigators and prosecutors.

For more information visit www.ey.com/fids or contact Ted Acosta, Principal, Fraud Investigation & Dispute Services +1 212 773 3022 (ted.acosta@ey.com), Mariusz Witalis, Partner, Fraud Investigation & Dispute Services +48 22 557 7950, (Mariusz.Witalis@pl.ey.com), or Rajiv Joshi, Partner, Fraud Investigation & Dispute Services +91 22 61921569 (rajiv.joshi@in.ey.com)

PwC Global Pharmaceuticals and Life Sciences Industry Group

The Global Pharmaceuticals and Life Sciences Industry Group at PwC is dedicated to delivering effective solutions to the complex business challenges facing pharmaceutical and life sciences companies. A global leader in serving the pharmaceutical and life sciences industry, PwC has extensive experience working with companies on industry-specific strategic, operational, and financial issues. Our capabilities include assurance, tax and advisory services, as well as industry specialised services in regulatory compliance, risk management, and transaction support. In helping our clients, we draw on the full knowledge and skills of PwC’s professionals. More than 223,400 people in 157 countries connect their thinking, experience and solutions to build public trust and enhance value for clients and their stakeholders.

For more information, visit www.pwc.com/pharma.

Baker McKenzie

Our lawyers have acted as trusted advisers to the world’s largest healthcare companies for more than half a century. Among the first firms to provide comprehensive industry advice — covering biopharmaceuticals, medical devices, and healthcare services — we have broad experience and a sophisticated understanding of the global life sciences market that few can match. We help healthcare companies soundly navigate intensifying legal and commercial risks, realize opportunities for expansion and growth, and stay ahead of the innovation curve.

Our international network spans 47 countries, including the largest healthcare markets in the world. Many of our practices — including M&A, Tax, Compliance, Healthcare Regulatory, Employment, Intellectual Property, and Dispute Resolution — are ranked among the world’s leading. Our lawyers have developed a depth of knowledge in the industry in respect of various market players including manufacturers, distributors, research institutions, clinical trial bases and health and regulatory authorities. For more information www.BakerMcKenzie.com.

Davis Wright Tremaine

Those of us in the Davis Wright Tremaine health care practice group devote nearly all of our time to industry-specific matters. This allows us to develop niche practices within the field that serve needs unique to the health care market. We also understand the business issues and regulatory developments that affect health care delivery and compliance, and as a unified team we can match the attorney with the niche expertise that best addresses client needs. For more information visit our website at www.DWT.com.

Hogan Lovells

Hogan Lovells is a global legal practice that helps corporations, financial institutions, and governmental entities across the spectrum of their critical business and legal issues globally and locally. We have over 2,500 lawyers operating out of more than 45 offices in the United States, Europe, Latin America, the Middle East, Africa, Australia and Asia. With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, including many with experience at the FDA, CMS and other key agencies and in industry, and others holding advanced degrees in relevant disciplines, we offer timely, effective counsel on matters that include product development, approval and post-approval compliance, and the development of next-generation products. High rankings in Chambers, Legal 500, and other global directories speak to the quality and impact of our services.

Whether your products are traditional drugs or biotechnology products, we work with you to successfully develop and commercialize products, addressing issues of regulatory approvals and compliance; coverage, reimbursement, and pricing; and careful use of intellectual property and regulatory exclusivities to manage product life cycles. Our multidisciplinary team leverages the skills and experience of colleagues in other disciplines – including healthcare compliance (such as coverage, reimbursement, pricing, and fraud and abuse prevention), public policy, intellectual property, corporate and securities law, and litigation – to provide integrated, strategic, and practical advice for successful product development and marketing and effective responses to regulators and competitors.

For more information, visit www.hoganlovells.com.

King & Spalding

Celebrating more than 130 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 900 lawyers in 19 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, for uncompromising commitment to quality and for dedication to understanding the business and culture of its clients. King & Spalding was recently chosen by U.S. News & World Report and Best Lawyers as the “Law Firm of the Year” for FDA law and LMG Life Sciences selected the firm as one of the finalists for “Regulatory Firm of the Year.”

For more information about our FDA & Life Sciences practice, please contact Mark Brown at (202) 626-5443. www.kslaw.com

Navigant

Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global professional services firm that helps clients take control of their future. With more than 3,000 life sciences and healthcare consultants to help you navigate the complex regulatory environment of Pharmaceutical, Biotech, Medical Device and Diagnostics industries, we apply our deep industry knowledge, technical expertise, and strategic approach to offer solutions and deliver powerful results. From the synthesis of highly complex healthcare transactions, rules, regulations, data, documents and business practices to bring meaningful value to the co-development of a dispute, regulatory, compliance or investigation strategy and execution, we help clients help clients build, manage, and/or protect their business interests.

More information about Navigant can be found at www.navigant.com.

Paul Hastings

Paul Hastings provides innovative compliance and legal solutions to many of the world’s top pharmaceutical and life sciences companies, large and small, in markets across Asia, Europe, Latin America, and the United States. We offer a complete portfolio of services to support our clients’ complex, often mission-critical needs–from structuring transactions, to protecting critical intellectual property, to resolving complicated U.S. healthcare and global anti-corruption enforcement matters, to providing the savvy compliance and legal counsel that keeps business moving forward.

Paul Hastings has grown steadily and strategically along with our clients across global markets in the critical pharmaceutical and life sciences sector. We have a significant and strategic presence across Europe, and were one of the first U.S. law firms to establish a presence in Asia, where we continue to be a leader in the region, and have significantly expanded our support for clients in Brazil, out of our new São Paulo office, and other emerging markets of Latin America.

More information can be found at www.PaulHastings.com.

Polaris

Polaris is the world’s leading healthcare compliance software and consulting firm, providing innovative solutions to Life Sciences companies.

Our services range from best-in-class compliance software to expert consulting, planning and strategic guidance from the industry’s leading compliance authorities. Polaris also offers competitive data analytics and end-to-end managed services.

Polaris is headquartered in New York City, with worldwide offices in Amsterdam, Boston, Hong Kong, New Brunswick, Paris and San Francisco.

Since 2001, the world’s most recognized pharmaceutical, biotech and medical device companies have relied on Polaris as their trusted life sciences compliance solutions partner. Learn more at www.polarismanagement.com.

Porzio Life Sciences

Porzio Life Sciences helps pharmaceutical, medical device and biotechnology companies satisfy federal, state and ex-US marketing and sales obligations. Our best-in-class compliance solutions include: the Porzio Compliance Digest, with real-time databases of enacted laws, pending legislation and government enforcement actions; Porzio AggregateSpendID®, which tracks and reports healthcare provider and organization expenditures; and Porzio GST®, which enables companies to capture and manage data for meeting reporting obligations in almost 40 ex-US jurisdictions. Further, Porzio Life Sciences provides compliance services, such as assistance with acquiring and maintaining distribution licenses. For information, visit www.porziolifesciences.com.

Sidley

Sidley’s global life sciences practice comprises a team of multidisciplinary lawyers with a deep understanding of the issues innovators face—from the science and technology to the business realities. Harnessing a breadth of experience, we represent prominent pharmaceutical, biotechnology, medical device, dietary supplements and food clients on a range of regulatory, compliance and enforcement issues. Strong advocacy on behalf of our clients consistently earns our team acknowledgement from industry publications. This includes being named “Life Cycle Firm of the Year” at the inaugural LMG Life Sciences Awards in 2016. We also received first-tier national rankings in Biotechnology Law, FDA Law and Healthcare Law in the U.S. News — Best Lawyers® “Best Law Firms” rankings for the seventh consecutive year, and each year since the survey’s inception. In addition, our service and responsiveness earned us recognition in the BTI Industry Power Rankings as a “Most Recommended Law Firm in the Pharmaceutical Industry.”

For more information please visit www.Sidley.com.

Skadden, Arps, Slate, Meagher & Flom LLP

With 22 offices, approximately 1,700 attorneys and more than 50 distinct areas of practice, Skadden, Arps, Slate, Meagher & Flom LLP and affiliates serves clients in every major international financial center, providing the specific legal advice companies across a spectrum of industries need to compete most effectively in a global business environment. Our clients include approximately 50 percent of the Fortune 250 industrial and service corporations, as well as financial and governmental entities, small, entrepreneurial companies and nonprofits. Skadden’s attorneys and staff share a commitment to providing our clients with the highest-quality and most cost-effective legal services in an atmosphere emphasizing teamwork, creativity, responsiveness and diversity.

For more information visit www.Skadden.com.